August 31, 2022

Samuel Chen


PhD, Bioengineering (Home School – Mechanical Engineering), Georgia Institute of Technology (2022 – Present) 
BS, Mechanical Engineering w/ minor in Chemistry (2018 – 2022)


Sam joined the Sulchek Lab in Fall 2022 as a PhD student. During his undergrad at the University of Washington, he developed a urine specimen processing device that enriches a biomarker to enable sensitive diagnosis of active tuberculosis disease at the point-of-care. He also worked on a microfluidic biochemical assay for analyzing signaling pathways of single cells at high throughput.

Outside of Georgia Tech, he is the co-founder and chief technology officer of Truly Technologies, a company that develops bioprocessing solutions for concentrating analytes of interest and removing sample background matrix.

During his free time, he enjoys hiking, kayaking, and spending time with family and friends.

Research Project:

For his PhD research, Sam is developing novel and high throughput microfluidic platforms for

1. fundamental study of single cell mechanics in unexplored regimes,
2. scalable production of monodispersed and mechanically tunable micro/nanodroplets, and
3. efficient delivery of payloads into cells for cell therapy engineering and in vivo tracking applications.

Honors and Fellowships:

GT NEXT Award, Georgia Tech Office of Licensing
Topping Fellowship, Woodruff School of Mechanical Engineering, Georgia Tech

Publications: Google Scholar

Contact Information:

LinkedIn: Samuel Chen 
Office: Parker H. Petit Institute for Bioengineering and Biosciences 
315 Ferst Drive, 2A Offices, Atlanta, GA 30332